Jon Burg

Team: Leadership

Job Title: Jon Burg

Bio: Jon is a Partner and practice leader at Infinite Equity. Jon has a passion for equity compensation with over 20 years of experience guiding companies from initial idea to full execution with the ability to maximize the value of the programs offered. Jon leverages an extensive actuarial background to apply an added rigor and discipline to the design, valuation, and implementation of employee equity compensation programs. Jon previously held roles leading global equity compensation teams and recently served as the Vice Chairman of the Global Equity Organization’s (GEO) Board of Directors. Jon has a Bachelor of Science in Mathematics and Economics from University of Washington, is a Fellow of the Society of Actuaries, and is a certified equity professional. He is based in San Francisco.

Recent Posts By

Jon Burg

Indexed Stock Options

Indexed Stock Options

Time-based stock options are a main-stay of executive compensation, but with a few recent developments and uncertainty about the future, now is the right time to give Indexed options another look.

The Case for an ESPP at IPO Guide

The Case for an ESPP at IPO

Pre-IPO is a unique and exciting time in the lifecycle of a company, and with careful planning companies can take advantage of that to maximize their ESPP.

Design Levers to Lower the RTSR Fair Value

negative-space-industrial-gears-machine-Design-Levers

Performance shares earned contingent on a performance metric of Relative Total Shareholder Return (RTSR) is the most prevalent globally as seen in the marketplace.  Performance awards that are contingent on Relative TSR are deemed market conditions and will generally require a Monte Carlo simulation to determine the fair value under ASC718.  Unfortunately, the fair value…

The Valuation of Non-Vesting Conditions under IFRS 2

shutterstock_1050425945

If a plan allows for retirement-eligible award holders to continue to earn their awards after retirement, what initially looks like a performance condition could actually be a “non-vesting” condition under IFRS 2. Non-vesting conditions should be considered in the estimation of fair value and could drastically lower your company’s expense.